Literature DB >> 25459756

Chemical profiling with HPLC-FTMS of exogenous and endogenous chemicals susceptible to the administration of chotosan in an animal model of type 2 diabetes-induced dementia.

Yimin Niu1, Feng Li1, Chikako Inada1, Ken Tanaka1, Shiro Watanabe1, Hironori Fujiwara1, Sachie Sasaki-Hamada2, Jun-Ichiro Oka2, Kinzo Matsumoto3.   

Abstract

In our previous study, the daily administration of chotosan (CTS), a Kampo formula consisting of Uncaria and other 10 different crude drugs, ameliorated cognitive deficits in several animal models of dementia including type 2 diabetic db/db mice in a similar manner to tacrine, an acetylcholinesterase inhibitor. The present study investigated the metabonomics of CTS in db/db mice, a type 2 diabetes model, and m/m mice, a non-diabetes control strain, to identify the exogenous and endogenous chemicals susceptible to the administration of CTS using high performance liquid chromatography equipped with an orbitrap hybrid Fourier transform mass spectrometer. The results obtained revealed that the systemic administration of CTS for 20 days led to the distribution of Uncalia plant-derived alkaloids such as rhynchophylline, hirsuteine, and corynoxeine in the plasma and brains of db/db and m/m mice and induced alterations in four major metabolic pathways; i.e., (1) purine, (2) tryptophan, (3) cysteine and methionine, (4) glycerophospholipids in db/db mice. Moreover, glycerophosphocholine (GPC) levels in the plasma and brain were significantly higher in CTS-treated db/db mice than in vehicle-treated control animals. The results of the in vitro experiment using organotypic hippocampal slice cultures demonstrated that GPC (10-30 μM), as well as tacrine, protected hippocampal cells from N-methyl-d-aspartate-induced excitotoxicity in a manner that was reversible with the muscarinic receptor antagonist scopolamine, whereas GPC had no effect on the activity of acetylcholinesterase in vitro. Our results demonstrated that some CTS constituents with neuropharmacological activity were distributed in the plasma and brain tissue following the systemic administration of CTS and may subsequently have affected some metabolic pathways including glycerophospholipid metabolism and cognitive function in db/db mice. Moreover, the present metabonomic analysis suggested that GPC is a putative endogenous chemical that may be involved in the tacrine-like actions of CTS in the present diabetic animal model.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chotosan; Glycerophosphocholine; HPLC-FTMS; Metabonomics; Type 2 diabetic model

Mesh:

Substances:

Year:  2014        PMID: 25459756     DOI: 10.1016/j.jpba.2014.11.019

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  6 in total

1.  Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia.

Authors:  Yanrong Zheng; Zhe Shen; Xiaoli Wu; Lei Jiang; Weiwei Hu; Zhong Chen; Xiangnan Zhang
Journal:  J Vis Exp       Date:  2017-07-31       Impact factor: 1.355

2.  Quantitative imaging of natural products in fine brain regions using desorption electrospray ionization mass spectrometry imaging (DESI-MSI): Uncaria alkaloids as a case study.

Authors:  Lei Gao; Zijia Zhang; Wenyong Wu; Yanping Deng; Haijuan Zhi; Huali Long; Min Lei; Jinjun Hou; Wanying Wu; De-An Guo
Journal:  Anal Bioanal Chem       Date:  2022-05-31       Impact factor: 4.142

3.  Comorbidity Analysis between Alzheimer's Disease and Type 2 Diabetes Mellitus (T2DM) Based on Shared Pathways and the Role of T2DM Drugs.

Authors:  Reagon Karki; Alpha Tom Kodamullil; Martin Hofmann-Apitius
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

4.  Integrated 16S rRNA Sequencing, Metagenomics, and Metabolomics to Characterize Gut Microbial Composition, Function, and Fecal Metabolic Phenotype in Non-obese Type 2 Diabetic Goto-Kakizaki Rats.

Authors:  Weijun Peng; Jianhua Huang; Jingjing Yang; Zheyu Zhang; Rong Yu; Sharmeen Fayyaz; Shuihan Zhang; Yu-Hui Qin
Journal:  Front Microbiol       Date:  2020-01-20       Impact factor: 5.640

5.  Analysis of chemical properties of edible and medicinal ginger by metabolomics approach.

Authors:  Ken Tanaka; Masanori Arita; Hiroaki Sakurai; Naoaki Ono; Yasuhiro Tezuka
Journal:  Biomed Res Int       Date:  2015-10-01       Impact factor: 3.411

6.  A Systematic Strategy for Discovering a Therapeutic Drug for Alzheimer's Disease and Its Target Molecule.

Authors:  Zhiyou Yang; Tomoharu Kuboyama; Chihiro Tohda
Journal:  Front Pharmacol       Date:  2017-06-19       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.